Hbk Investments L P Fibrogen Inc Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $312,659 - $437,343	-7,300 Reduced 16.74%	36,300 $1.97 Million
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $58,955 - $80,145	1,300 Added 3.07%	43,600 $2.01 Million
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $625,013 - $895,429	-14,899 Reduced 26.05%	42,300 $2.01 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $1.91 Million - $3.08 Million	57,199	57,199 $3.08 Million

37.4M

351K

105K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.